BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5746328)

  • 1. Experience with low molecular weight dextran in patients with thrombocytosis.
    Tytgat GN; De Vreker RA; Lust A
    Acta Anaesthesiol Belg; 1968; 19(2):183-92. PubMed ID: 5746328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet functions following dextran administration].
    Cronberg S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):491-6. PubMed ID: 4193166
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of different plasma volume expanders (rheomacrodex and haemaccel) on the fibrinolytic system and some platelet functions.
    Fischer M
    Bibl Haematol; 1969; 33():457-65. PubMed ID: 5384013
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of heparin, tranexamic acid, and low molecular weight dextran on pulmonary microvascular occlusions following aortic cross-clamping.
    Lim RC; Bergentz SE
    Bibl Anat; 1969; 10():480-8. PubMed ID: 5407404
    [No Abstract]   [Full Text] [Related]  

  • 5. [The increase of streptokinase effect by low molecular weight dextran].
    Vinazzer H; Bergmann H
    Wien Med Wochenschr; 1968 Apr; 118(15):337-40. PubMed ID: 5726102
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of low molecular dextrans on the survival of fibrinogen and platelets in rabbits (author's transl)].
    Heyes H; Leucht W; Slijepcevic B
    Anaesthesist; 1980 Jul; 29(7):379-84. PubMed ID: 6158886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of infusion of dextran 70 on fibrinolysis inhibition activity in human serum.
    Carlin G; Modig J; Saldeen T
    Acta Chir Scand; 1979; 145(3):129-31. PubMed ID: 494957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dextran and induced thrombocytopenia on the lysability of ex vivo thrombi in dogs.
    Aberg M; Bergentz SE; Hedner U
    Acta Chir Scand; 1977; 143(2):91-4. PubMed ID: 899594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolysis after renal transplantation.
    Ljungqvist U; Bergentz SE; Leandoer L; Nilsson IM
    Scand J Urol Nephrol; 1969; 3(1):23-9. PubMed ID: 4900740
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of thrombin infusions upon 131-I-labelled fibrinogen in dogs.
    Nordström S; Zetterqvist E
    Acta Physiol Scand; 1968; 72(1):85-99. PubMed ID: 5301454
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of low molecular weight dextran and thrombin infusions on blood platelets and fibrinogen.
    Abildgaard U; Skjörten F
    J Atheroscler Res; 1968; 8(1):69-76. PubMed ID: 5642106
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dextran on fibrinolysis inhibition activity in serum.
    Carlin G; Saldeen T
    Thromb Res; 1978 Jun; 12(6):1165-75. PubMed ID: 151346
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of Dextran-65 Polfa on the blood clotting system].
    Badowski A; Stanowski E; Pelasa J
    Wiad Lek; 1973 May; 26(10):889-94. PubMed ID: 4710728
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental studies on the antithrombotic effect of dextran.
    Bygdeman S
    Acta Chir Scand Suppl; 1968; 387():44-9. PubMed ID: 5256243
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressive effect of dextran on platelet adhesiveness.
    Cronberg S; Robertson B; Nilsson IM; Niléhn JE
    Thromb Diath Haemorrh; 1966 Dec; 16(3):384-94. PubMed ID: 5996665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Low molecular weight dextran and fibrinolysis in humans. I. Comparison between fibrinolysis activation by administering low molecular weight dextran by intravenous and intra-arterial routes].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):200-15. PubMed ID: 5633532
    [No Abstract]   [Full Text] [Related]  

  • 17. [The progress and the fibrinolytic activity of the diabetic retinopathy treated with dextran sulfate (author's transl)].
    Mine T
    Nippon Ganka Gakkai Zasshi; 1975 Apr; 79(4):371-5. PubMed ID: 1170740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Low molecular weight dextran and fibrinolysis in men. II. Fibrinolysis activation by administering low molecular weight dextran in lymphedema].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):216-32. PubMed ID: 5633533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebrovascular diseases. 7. Dextran treatment during thrombotic diseases].
    Bygdeman S
    Lakartidningen; 1969 Oct; 66(40):4090-3. PubMed ID: 5384311
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of dextran 70 on the intra- and postoperative behaviour of haemostasis.
    Kladetzky RG; Popov-Cenić S; Müller N; Hack G; Lang U
    Bibl Anat; 1977; (16 Pt 2):463-5. PubMed ID: 603582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.